Genetic Polymorphisms CYP3A4*22, CYP3A5*3, and CYP2D6 Predicted Phenotypes Are Not Associated with Antipsychotic Treatment Outcomes in Neurotypical Prepubertal Boys with Conduct Disorders.

Ivashchenko DV, Che MD, Aysin FR, Tuchkova SN, Korsakov IN, Ianavichiute EI, Ivashchenko MA, Shimanov PV, Kondratieva RV, Shubin AV, Mirzaev KB, Shevchenko YS, Sychev DA

Open source

DOI
10.3390/ph19091401
Published
2026 Sep 4
Container
Pharmaceuticals (Basel, Switzerland)
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/ph19091401,
  title = {Genetic Polymorphisms CYP3A4*22, CYP3A5*3, and CYP2D6 Predicted Phenotypes Are Not Associated with Antipsychotic Treatment Outcomes in Neurotypical Prepubertal Boys with Conduct Disorders.},
  author = {Ivashchenko DV and Che MD and Aysin FR and Tuchkova SN and Korsakov IN and Ianavichiute EI and Ivashchenko MA and Shimanov PV and Kondratieva RV and Shubin AV and Mirzaev KB and Shevchenko YS and Sychev DA},
  year = {2026},
  journal = {Pharmaceuticals (Basel, Switzerland)},
  doi = {10.3390/ph19091401},
  url = {https://doi.org/10.3390/ph19091401}
}

RIS

TY  - JOUR
TI  - Genetic Polymorphisms CYP3A4*22, CYP3A5*3, and CYP2D6 Predicted Phenotypes Are Not Associated with Antipsychotic Treatment Outcomes in Neurotypical Prepubertal Boys with Conduct Disorders.
AU  - Ivashchenko DV
AU  - Che MD
AU  - Aysin FR
AU  - Tuchkova SN
AU  - Korsakov IN
AU  - Ianavichiute EI
AU  - Ivashchenko MA
AU  - Shimanov PV
AU  - Kondratieva RV
AU  - Shubin AV
AU  - Mirzaev KB
AU  - Shevchenko YS
AU  - Sychev DA
PY  - 2026
JO  - Pharmaceuticals (Basel, Switzerland)
DO  - 10.3390/ph19091401
UR  - https://doi.org/10.3390/ph19091401
ER  - 

APA

DV, I., MD, C., FR, A., SN, T., IN, K., EI, I., MA, I., PV, S., RV, K., AV, S., KB, M., YS, S., & DA, S. (2026). Genetic Polymorphisms CYP3A4*22, CYP3A5*3, and CYP2D6 Predicted Phenotypes Are Not Associated with Antipsychotic Treatment Outcomes in Neurotypical Prepubertal Boys with Conduct Disorders.. Pharmaceuticals (Basel, Switzerland). https://doi.org/10.3390/ph19091401

Source records